1Bukowski RM,Hewlett JS,Harris JW,et al.Exchange transfusions in the treatment of thrombotic thrombocytopenic purpura.Semin Hematol,1976,13(3):219-232.
2Rock GA,Shumak KH,Buskard NA,et al.Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura.Canadian Apheresis Study Group.N Engl J Med,1991,325(6):393-397.
4Wagner DD,Marder VJ.Biosynthesis of yon Willebrand protein by human endothelial cells.J Biol Chem,1983,258 (4):2065-2067.
5Furlan M,Robles R,Solenthaler M,et al.Deficient activity of yon Willebrand factor-cleaving protease in chronic relapsing thrombotic thrornbocytopenic purpura.Blood,1997,89 (9):3097-3103.
6Tsai HM.Physiologic cleavage of yon Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion.Blood,1996,87(10):4235-4244.
7Furlan M,Robles R,Solenthaler M,et al.Deficient activity of yon Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.Blood,1997,89 (9):3097-3103.
8Tsai H-M,Lian EC.Antibodies to yon Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.N Engl J Med,1998,339(22):1585-1594.
9Levy GG,Nichols WC,Lian EC,et al.Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.Nature,2001,413(6855):488-494.
10Veyradier A,Obert B,Houllier A,et al.Specific yon Willebrand factor-cleaving protease in thrombotic microangiopathies:a study of 111 cases.Blood,2001,98(6):1765-1772.
